Hruby Z, Smolska D, Filipowski H, Rabczyński J, Cieślar E, Kopeć W, Dulawa J
Department of Nephrology, University of Medicine, Wrocław, Poland.
J Intern Med. 1998 Mar;243(3):215-22. doi: 10.1046/j.1365-2796.1998.00277.x.
As tubulointerstitial damage is regarded secondary to glomerular injury in primary glomerulopathies, we assessed lesions to renal tubulointerstitium in recently diagnosed primary glomerular diseases and evaluated their impact on progression of the disease during the first 2 years after diagnosis.
A nonrandomized prospective study assessing tubulointerstitial morphometry at diagnosis, markers of tubular function within the next 6 months and progression of the disease (creatinine clearance) during 24 months' follow-up.
Single tertiary referral centre.
Forty-six patients with primary glomerular disease, the diagnostic oligobiopsy performed within 2 months of the onset of clinical symptoms.
All patients were subjected to antiinflammatory/immunosuppressive treatment.
Alterations in results of tubulointerstitial morphometry and tubular function tests, correlations between these variables and parameters of nephrosis/renal function, selection of the most accurate predictor of disease progression within 24 months after diagnostic biopsy.
Function of proximal tubules, markedly deteriorated at the time of diagnosis, significantly improved 6 months later (urinary beta2-microglobulin: P < 0.0025), along with reduction in proteinuria (P < 0.00125). No appreciable alterations in function of distal tubules were noted. Morphometric indices revealing interstitial expansion and tubular atrophy significantly correlated with creatinine clearance at 6 months (P = 0.032) and were the best predictors of deteriorating renal function at 24 months. Excretion of beta2-microglobulin at the time of diagnosis was the best marker for impairment of glomerular filtration 6 months later.
Significant damage to cortical tubulointerstitium occurs concurrently with glomerular injury in primary glomerulopathies and may predict the clinical course of the disease already in its initial phase.
由于在原发性肾小球疾病中,肾小管间质损伤被认为是继发于肾小球损伤,我们评估了近期诊断的原发性肾小球疾病中肾小管间质的病变情况,并评估了这些病变在诊断后的头2年对疾病进展的影响。
一项非随机前瞻性研究,评估诊断时的肾小管间质形态测量、接下来6个月内的肾小管功能标志物以及24个月随访期间的疾病进展(肌酐清除率)。
单一的三级转诊中心。
46例原发性肾小球疾病患者,在临床症状出现后2个月内进行诊断性寡肾活检。
所有患者均接受抗炎/免疫抑制治疗。
肾小管间质形态测量结果和肾小管功能测试的变化、这些变量与肾病/肾功能参数之间的相关性、诊断性活检后24个月内疾病进展最准确预测指标的选择。
近端肾小管功能在诊断时明显恶化,6个月后显著改善(尿β2-微球蛋白:P<0.0025),同时蛋白尿减少(P<0.00125)。未观察到远端肾小管功能有明显改变。显示间质扩张和肾小管萎缩的形态测量指标与6个月时的肌酐清除率显著相关(P=0.032),是24个月时肾功能恶化的最佳预测指标。诊断时β2-微球蛋白的排泄是6个月后肾小球滤过受损的最佳标志物。
在原发性肾小球疾病中,皮质肾小管间质的显著损伤与肾小球损伤同时发生,并且可能在疾病的初始阶段就预测其临床进程。